Articles and Blogs

The Ninth Circuit’s (also referred to as the “Court”) decision in U.S. v. Schena (“Schena“) marks the first appellate interpretation of the Eliminating Kickback in Recovery Act of 2018 (“EKRA”). The Ninth Circuit held that EKRA extends to payments made to third-party marketers indirectly influencing referrals for medical testing services, expanding its scope beyond... READ MORE

As COVID-19-related testing capabilities increase along with other kinds of desired laboratory tests, clinical laboratories are encountering heightened volumes resulting from rising demand for services. Recovery homes and clinical treatment facilities may also see heightened demand for services stemming from the COVID-19 fall-out. In addition to this demand, these entities may wish to promote... READ MORE

On October 24, 2018, Congress enacted a new law titled the Eliminating Kickbacks in Recovery Act of 2018 (“EKRA”) as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (“SUPPORT Act”). The SUPPORT Act is a comprehensive law that seeks to combat the opioid... READ MORE